Search clinical trials for: oral naltrexone

Total 8579 results

National Institute on Alcohol Abuse and Alcoholism...

Completed

Naltrexone Treatment of Alcohol Dependence

Alcoholism

United States
USWM, LLC (dba US WorldMeds)
National Institute on Drug Abuse (NIDA)

Completed

Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects

Healthy

United States
Brigham and Women's Hospital
Harvard School of Public Health (HSPH); Mclean Hospital

Completed

Effectiveness of Alcohol Interventions Among Tuberculosis (TB) Patients in Tomsk Oblast, Russia (IMPACT)

Tuberculosis | Alcohol Use Disorders

Russian Federation
Eunice Kennedy Shriver National Institute of Child...

Unknown

Self-Injury: Diagnosis and Treatment

Self-Injurious Behavior | Mental Retardation

United States
University of Pennsylvania

Recruiting

Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder

Opioid Use Disorder

United States
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)

Completed

Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade

HIV | Methamphetamine Abuse

United States
Pain Therapeutics

Completed

Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse

Opioid-Related Disorders

United States
Burnasyan Federal Medical Biophysical Center

Completed

Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers

Angina Pectoris | Stroke, Not Specified as Hemorrhage or Infarction

Russian Federation
Universita di Verona
IGEA

Terminated

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

Pancreatic Cancer

Italy
Pfizer

Completed

Pharmacokinetics Study of ALO-02 and OxyContin

Management of Moderate to Severe Pain

United States
NYU Langone Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users

Alcohol Dependence | Alcohol Use Disorder

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA); Alkermes, Inc.

Completed

VIVITROL as a Treatment for Cocaine and Alcohol Dependence

Alcohol Dependence | Cocaine Dependence

United States
Pfizer

Completed

Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone

Healthy

United States
Massachusetts General Hospital
United States Department of Defense

Completed

Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist

ADHD | Stimulant-Induced Euphoria

United States
Allodynic Therapeutics, Inc

Not yet recruiting

Multi-Center Study of Naltrexone-Acetaminophen in Acute Migraine, With an Exploratory Analysis of Co-occurring Anxiety

Migraine
Mundipharma (China) Pharmaceutical Co. Ltd

Unknown

Buprenorphine Transdermal Patches Pharmacokinetic Study

Chronic Pain

China
Pfizer

Terminated

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

Moderate-severe Pain

United States
Pfizer

Terminated

Conversion to Embeda With Rescue Trial (ConvERT)

Pain | Chronic Disease

United States
Glenn-Milo Santos
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM

Methamphetamine Use Disorder

United States
GlaxoSmithKline

Completed

[11C]Carfentanil PET Study of GSK1521498

Obesity

United Kingdom
NYU Langone Health
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Completed

Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry (XOR)

Opioid-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Dronabinol Naltrexone Treatment for Opioid Dependence (Domino)

Opioid Dependence

United States
Copenhagen University Hospital at Herlev

Withdrawn

Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy

Ulcerated Cutaneous Metastases

Denmark
Université de Montréal
St. Justine's Hospital

Terminated

Comparison of Two Oral Myofunctional Reeducation Methods for Children With Obstructive Sleep Apnea (PERSIST-B)

Obstructive Sleep Apnea

Canada
University of Pennsylvania

Not yet recruiting

Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder

Opioid Dependence
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Naltrexone for Pre-release Prisoners

Opiate Addiction

United States
Alza Corporation, DE, USA

Completed

A Study to Evaluate the Safety of D-TRANS Fentanyl With Naltrexone in Adult Patients With Chronic Pain and Who Are Opioid Tolerant

Chronic Pain
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Associacao Fundo de Incentivo...

Completed

Effects of Omegas 3 and 6 on Alcohol Dependence

Alcohol Dependence

Brazil
National Development and Research Institutes, Inc.
St. Luke's-Roosevelt Hospital Center

Unknown

Science-Based Treatment for Opioid-Dependent Adolescents

Opioid-Dependence Among Adolescents

United States
Allodynic Therapeutics, Inc

Completed

The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination

Migraine With or Without Aura

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Extended Release Naltrexone for Opioid-Dependent Youth

Drug Dependence

United States
Elite Laboratories, Inc

Completed

A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects

Withdrawal Symptoms

United States
Central Institute of Mental Health, Mannheim
German Federal Ministry of Education and Research; Heidelberg University -... and other collaborators

Completed

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder (ON-ICE)

Alcoholism | Alcohol Use Disorder | Alcohol Addiction

Germany
Allodynic Therapeutics, LLC

Completed

Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)

Chronic Low Back Pain | Lumbar Radiculopathy

United States
Ensysce Biosciences
PRA Health Sciences

Completed

Study of PF614 Compared to OxyContin® in Healthy Volunteers (SAD)

Healthy

United States
Pfizer

Completed

A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain

Low Back Pain | Chronic Pain | Analgesia

United States
University of Vermont Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Effective Treatment for Prescription Opioid Abuse

Prescription Opioid Dependence

United States
Estetra
ICON Clinical Research

Completed

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort)

Vasomotor Symptoms | Menopausal Symptoms

United States, Canada
Friends Research Institute, Inc.

Recruiting

Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

Opioid-use Disorder

United States
Pfizer

Completed

Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo

Chronic Pain | Analgesia | Opioid-related Disorders | Narcotic Abuse
Minia University

Completed

The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer

Cornea Ulcer

Egypt
Pfizer

Completed

Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain

Chronic Noncancer Pain

United States
Pfizer

Completed

Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain

Pain

United States
Pulmagen Therapeutics

Completed

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma

Atopic Asthma

United Kingdom
University of Missouri-Columbia

Completed

Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation

Constipation Drug Induced

United States
Turning Point Therapeutics, Inc.

Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Lymphoma | Locally Advanced Solid Tumors | Metastatic Solid Tumors | Primary CNS Tumors

United States, Korea, Republic of, Spain, Singapore, Taiwan, Australia, Italy, Canada, France, Denmark, United Kingdom
Mansoura University

Completed

Clinical Impacts of Oral Gastrografin Follow Through in Adhesive Small Bowel Obstruction (SBO)

Small Bowel Obstruction

Egypt
German Institute of Human Nutrition
Ludwig-Maximilians - University of Munich

Completed

Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 1 (ILIAS-1)

Diabetes | Pre-diabetes

Germany
Centro Universitario La Salle
Hospital de Clinicas de Porto Alegre

Completed

LDN and tDCS in Fibromyalgia

Fibromyalgia

Brazil
Applied Molecular Transport

Active, not recruiting

Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

Ulcerative Colitis

United States, Hungary, Ukraine, Germany, United Kingdom, Belarus, Bulgaria, Canada, France, Georgia, Moldova, Republic of, Poland, Russian Federation, Switzerland

Search clinical trials for: oral naltrexone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations